Strides Shasun receives tentative nod from USFDA for HIV drug Efavirenz

Posted on:27 May 2016 14:36:06

Strides Shasun receives tentative nod from USFDA for HIV drug Efavirenz
27 May 2016 Current Affairs: Strides Shasun has announced that it has received tentative approval from the U.S. Food and Drug Administration (USFDA) for Efavirenz tablets USP, 600 mg on 26 May 2016.

The final approval will be received after patent expiry in August 2018. The company will manufacture the product at its oral dosage facility in Bengaluru.

About Efavirenz : Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI).It is used as part of Highly Active Antiretroviral Therapy (HAART) for the treatment of a Human Immunodeficiency Virus (HIV) type 1. It is also used in combination with other antiretroviral agents as part of an expanded postexposure prophylaxis regimen to reduce the risk of HIV infection in people exposed to a significant risk. It was discovered at Merck Research Laboratories.It is on the WHO Model List of Essential Medicines, the most important medication needed in a basic health system.

Strides Shasun : Strides Arcolab is an Indian pharmaceutical company, headquartered at Bangalore in southern India.The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals.The company has 15 manufacturing sites in six countries and marketing presence in 50 countries.The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India.

Strides Arcolab changed name to Strides Shasun Ltd after an amalgamation of Shasun Pharmaceuticals with Strides Arcolab.Arun Kumar is the founder and Group CEO, and has been on the Board as Managing Director since its inception.


Subscribe to Current Affairs

Enter your email to get daily current affairs

Current Affairs July 2017

28 JULY
NEWS
27 JULY
NEWS
26 JULY
NEWS
25 JULY
NEWS

Current Affairs June 2017

30 JUNE
NEWS
29 JUNE
NEWS
28 JUNE
NEWS
27 JUNE
NEWS

Current Affairs May 2017

31 MAY
NEWS
30 MAY
NEWS
29 MAY
NEWS
27 MAY
NEWS